Precision Neuroscience Corp filed a Form D with the SEC, reporting $250.0M sold.
What happened
Precision Neuroscience is a New York-based brain-computer interface company developing a minimally invasive digital connection to the brain for people with paralysis and other neurologic conditions. The company raised approximately $250.0M from 46 investors, a major financing that signals serious momentum and makes it relevant to vendors selling into clinical, medtech, and hospital markets.
Source
Extracted by Autobound
From the Signal API record- Signal
- Form D offering
What this signalsNew funding often brings new budget and vendor reviews.
- Amount
- $250M
- Industry group
- Other Health Care
- Headquarters
- New York, NY
- Location
- New York, NEW YORK
- Filed
- Sep 28, 2026
- Jurisdiction
- Delaware
More from Precision Neuroscience Corp
- Funding roundPrecision Neuroscience Secures $250M Series D RoundFunding round
More form D offering signals at other companies
- Form D offeringPOPHOUSE AVATAR NETWORK INC.POPHOUSE AVATAR NETWORK INC. filed a Form D with the SEC, reporting $128.5M sold, of a $257M offering.Form D offering
- Form D offeringWESTPORT FUEL SYSTEMS INC.WESTPORT FUEL SYSTEMS INC. filed a Form D with the SEC, of a $25M offering.Form D offering
- Form D offeringKanin Energy, LLCKanin Energy, LLC filed a Form D with the SEC, reporting $18.6M sold, of a $60M offering.Form D offering
The full record
From the Signal API recordPeople
- Michael MagerExecutive Officer, Director · Named in the filing
- Konstantinos AlatarisExecutive Officer, Director · Named in the filing
- Craig MermelExecutive Officer, Director · Named in the filing
- Benjamin RapoportExecutive Officer, Director · Named in the filing
- Ravi MehtaDirector · Named in the filing
- Howard MorganDirector · Named in the filing
- Michael KaswanExecutive Officer · Named in the filing
- Michael GollerDirector · Named in the filing
Numbers
- Amount (USD)
- $250M
- Investors
- 46
Details
- CIK
- 0001858288
- Website
- precisionneuro.io
- Form
- D
- Entity type
- Corporation
- Primary topic
- Biotech Fundraise
- Revenue range
- Decline to Disclose
- Business state
- NY
- Accession number
- 0001123292-26-001327
- Resolved entity type
- Operating company
- Has non accredited investors
- No
- Filer
- Precision Neuroscience Corp
- Resolved name
- Precision Neuroscience
Topics and mentions
Topics
- Neurotech
- Medical Devices
- Healthcare Growth
- Clinical Partnerships
- FDA Clearance
Exemptions
- 06b
Securities
- Equity
Extraction
- Confidence
- High
- Relevance
- 86%
- Detected
- Sep 28, 2026
- signal_type
sec-form-d-funding- signal_subtype
newFilingCompany
Use this data
Get every form D offering signal for Precision Neuroscience Corp and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Precision Neuroscience Corp this week?”
Send it to your own tools
The Signal API returns form D offering signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-form-d-funding record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/fd-0001123292-26-001327 returns this record as JSON. POST /v1/companies/enrich returns every signal for precisionneuro.io.
{
"signal_id": "fd-0001123292-26-001327",
"signal_type": "sec-form-d-funding",
"signal_subtype": "newFilingCompany",
"detected_at": "2026-09-28T00:00:00+00:00",
"company": {
"name": "Precision Neuroscience Corp",
"domain": "precisionneuro.io"
},
"data": {
"cik": "0001858288",
"phone": "646-771-5881",
"detail": "This financing suggests Precision Neuroscience is in a late early-stage to growth-stage phase, with enough capital to push clinical validation, expand hospital partnerships, and advance regulatory/commercial readiness. Based on its website, the company is likely spending on clinical studies, product development, FDA/regulatory work, and scaling its Layer 7 cortical interface platform. Vendors should watch for opportunities in medical device manufacturing, clinical trial services, hospital procurement, data/AI infrastructure, and regulatory/compliance support.",
"topics": [
"Neurotech",
"Medical Devices",
"Healthcare Growth",
"Clinical Partnerships",
"FDA Clearance"
],
"summary": "Precision Neuroscience is a New York-based brain-computer interface company developing a minimally invasive digital connection to the brain for people with paralysis and other neurologic conditions. The company raised approximately $250.0M from 46 investors, a major financing that signals serious momentum and makes it relevant to vendors selling into clinical, medtech, and hospital markets.",
"website": "https://precisionneuro.io",
"location": "New York, NEW YORK",
"file_date": "2026-09-28",
"form_type": "D",
"relevance": 0.86,
"confidence": "high",
"exemptions": [
"06b"
],
"filing_url": "https://www.sec.gov/Archives/edgar/data/1858288/000112329226001327/",
"source_url": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001858288&type=D&dateb=&owner=include&count=40",
"entity_name": "Precision Neuroscience Corp",
"entity_type": "Corporation",
"jurisdiction": "DELAWARE",
"primary_topic": "Biotech Fundraise",
"revenue_range": "Decline to Disclose",
"business_state": "NY",
"industry_group": "Other Health Care",
"related_persons": [
{
"name": "Michael Mager",
"email": "m***@precisionneuro.io",
"roles": [
"Executive Officer",
"Director"
],
"linkedin_url": "linkedin.com/in/michael-mager-b458437"
},
{
"name": "Konstantinos Alataris",
"roles": [
"Executive Officer",
"Director"
]
},
{
"name": "Craig Mermel",
"email": "c***@precisionneuro.io",
"roles": [
"Executive Officer",
"Director"
],
"linkedin_url": "linkedin.com/in/craig-mermel-62a79b4"
},
{
"name": "Benjamin Rapoport",
"roles": [
"Executive Officer",
"Director"
]
},
{
"name": "Ravi Mehta",
"roles": [
"Director"
]
},
{
"name": "Howard Morgan",
"roles": [
"Director"
]
},
{
"name": "Michael Kaswan",
"roles": [
"Executive Officer"
]
},
{
"name": "Michael Goller",
"roles": [
"Director"
]
}
],
"total_investors": 46,
"accession_number": "0001123292-26-001327",
"securities_types": [
"Equity"
],
"business_location": "New York, NY",
"total_amount_sold": 249999984,
"resolved_entity_name": "Precision Neuroscience",
"resolved_entity_type": "operating_company",
"company_domain_confidence": 10,
"has_non_accredited_investors": false
}
}
curl https://signals.autobound.ai/v1/signals/fd-0001123292-26-001327 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"precisionneuro.io","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.